Showing results (181-190 of 195) with videos related to

Sort By:
Pageof 20
Pharmacology Research & Perspectives|September 4, 2020
Diabetes medication regimens and patient clinical characteristics in the national patient-centered clinical research network, PCORnetKatherine N Bachmann, Christianne L Roumie, Andrew D Wiese, et al.
Contemporary Clinical Trials|February 7, 2018
Promoting Successful Weight Loss in Primary Care in Louisiana (PROPEL): Rationale, design and baseline characteristicsPeter T Katzmarzyk, Corby K Martin, Robert L Newton, et al.
The American Journal of Cardiology|January 3, 2006
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference)John B Kostis, Graham Jackson, Raymond Rosen, et al.
The American Journal of Cardiology|July 16, 2005
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference)John B Kostis, Graham Jackson, Raymond Rosen, et al.
The New England Journal of Medicine|September 3, 2020
Weight Loss in Underserved Patients - A Cluster-Randomized TrialPeter T Katzmarzyk, Corby K Martin, Robert L Newton, et al.
Clinical Pharmacology and Therapeutics|June 6, 2025
Repurposing Acebutolol for Osteoporosis Treatment: Insights From Multi-Omics and Multi-Modal Data AnalysisDan-Yang Liu, Hui Shen, Jonathan Greenbaum, et al.
American Heart Journal|May 22, 2022
The trial to assess chelation therapy 2 (TACT2): Rationale and designGervasio A Lamas, Kevin J Anstrom, Ana Navas-Acien, et al.
JAMA Internal Medicine|March 3, 2025
Multivitamins After Myocardial Infarction in Patients With Diabetes: A Randomized Clinical TrialFrancisco Ujueta, Gervasio A Lamas, Kevin J Anstrom, et al.
Diabetes Care|June 23, 2025
Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone TreatmentRalph A DeFronzo, Vivian Fonseca, Vanita R Aroda, et al.
Diabetes Care|April 18, 2025
Prevalence of Hypercortisolism in Difficult-to-Control Type 2 DiabetesJohn B Buse, Steven E Kahn, Vanita R Aroda, et al.
Pageof 20